AKT1 and cancer: Our results indicated that along with the restraint of p-Src and p-AKT, the phosphorylation of c-Jun was inhibited, particularly under the joint effects of src inhibition and gemcitabine, which is in line with their inhibitory effects on deterring carcinogenesis and cancer progression.